Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials.

Abstract:

:There appears to be exceptional and growing public enthusiasm for botanical, or "herbal", medicines, especially amongst cancer patients. This has recently begun to be matched by increasing scientific attention. Whilst it is known that plant extracts are active against cancer, the standard approach has been to isolate, synthesize and administer the single chemical compound thought responsible for this effect. However, different components in a botanical may have synergistic activities. There is also some evidence that the presence of multiple compounds in a botanical extract can buffer the toxic effects of a single constituent. Though many of the botanicals popular among patients are probably not of benefit (e.g. Mistletoe, Pau D'arco), several botanicals have shown promise in Phase III (Sho-saiko-to, PSK) or Phase II (PC-SPES) trial. Quality control of botanicals poses significant challenges: small differences in genetics, soil, temperature, moisture and time of harvesting can lead to significant differences in the concentration of important constituents. Phase I and II methodology is also problematic: botanicals have low toxicity and are unlikely to cause rapid tumor regression. There is currently minimal regulation of botanical medicines.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Vickers A

doi

10.1081/cnv-120005926

subject

Has Abstract

pub_date

2002-01-01 00:00:00

pages

1069-79

issue

7-8

eissn

0735-7907

issn

1532-4192

journal_volume

20

pub_type

杂志文章,评审
  • Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer.

    abstract:BACKGROUND:Although treatment-related lymphopenia (TRL) is common in many cancers no data exists in rectal cancer. METHODS:Serial lymphocyte counts were analyzed retrospectively in patients with newly diagnosed rectal cancer, serial blood counts, and complete records at Johns Hopkins Hospital. RESULTS:Fifty-seven pat...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2018.1499028

    authors: Campian JL,Ye X,Sarai G,Herman J,Grossman SA

    更新日期:2018-01-01 00:00:00

  • Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC).

    abstract::The aim was to determine whether promoter methylation of BRCA1, MGMT, MLH1, RASSF1A, and p16 genes could predict response to platinum-based chemotherapy. Thirty-five subjects with epithelial ovarian cancer (EOC) treated by platinum-based chemotherapy were recruited. Methylation-specific polymerase chain reaction was c...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900902849699

    authors: Chaudhry P,Srinivasan R,Patel FD

    更新日期:2009-10-01 00:00:00

  • Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.

    abstract::The interaction of 5-fluorouracil and cyclophosphamide in the treatment of L1210 and P388 leukemias was studied using response surface methodology. Single dose treatment of each drug was administered simultaneously or with a 24-hr interval between 5-fluorouracil and cyclophosphamide to the advanced tumors or at variou...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908709020311

    authors: Wampler GL,Carter WH Jr,Campbell ED

    更新日期:1987-01-01 00:00:00

  • Genetic testing for inherited breast cancer risk in African Americans.

    abstract::As genetic testing for BRCA1 and BRCA2 (BRCA1/2) mutations is increasingly integrated into the clinical management of high-risk women, it will be important to understand barriers and motivations for genetic counseling among women from underserved minority groups to ensure equitable access to these services. Therefore,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-58819

    authors: Halbert CH,Kessler LJ,Mitchell E

    更新日期:2005-01-01 00:00:00

  • Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience.

    abstract:BACKGROUND:Hand-foot syndrome (HFS) has been previously reported as a side effect in 45-56% of patients treated with capecitabine. However, the natural history of HFS has not been fully characterized. In this study, we investigate the incidence, severity, and time course of HFS. DESIGN:Toxicity data collected for 41 p...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120000360

    authors: Abushullaih S,Saad ED,Munsell M,Hoff PM

    更新日期:2002-01-01 00:00:00

  • Paraneoplastic Neurologic Symptoms in a Pediatric Patient with Hodgkin Lymphoma.

    abstract::Neurological paraneoplastic syndromes are exceedingly rare, and often difficult to recognize clinically. Paraneoplastic achalasia is a condition characterized by new-onset dysphagia that is unrelated to tumor burden, most often due to the development of auto-immune antibodies targeting esophageal tissue. Due to the ra...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1852412

    authors: Baniel CC,Donaldson SS,Aftandilian C,Hiniker SM

    更新日期:2021-01-06 00:00:00

  • Vinorelbine (Navelbine): a third-generation vinca alkaloid.

    abstract::The vinca alkaloids represent one of the oldest classes of antineoplastic agents used in humans with a wide spectrum of activity against both animal and human tumors. These agents are known to inhibit microtubule polymerization. Vinorelbine is a semisynthetic analog that reached clinical trial on the basis of less pre...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909709047587

    authors: Budman DR

    更新日期:1997-01-01 00:00:00

  • Alterations in self-perceptions among adolescent cancer survivors.

    abstract::Psychosocial adjustment in adolescent cancer survivors has been documented to be quite variable. Factors mediating adjustment need to be identified. The current study is an exploration of the impact that cancer diagnosis and treatment has on adolescent's self-perceptions and the role this has in mediating adjustment i...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909109018956

    authors: Smith K,Ostroff J,Tan C,Lesko L

    更新日期:1991-01-01 00:00:00

  • Cancer diagnosis by discrimination between normal and malignant human blood samples using attenuated total reflectance-Fourier transform infrared spectroscopy.

    abstract::FTIR spectroscopy is a common technique for cancer diagnosis. Applied tissue samples are heterogeneous and may be damaged in preparation procedures. Easier sampling, more available samples and also easier process with assured results would be interesting. Whole blood samples include all of these qualifications and our...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/02770900701512555

    authors: Khanmohammadi M,Ansari MA,Garmarudi AB,Hassanzadeh G,Garoosi G

    更新日期:2007-09-01 00:00:00

  • Expression of Circadian Clock Genes in Human Colorectal Cancer Tissues Using Droplet Digital PCR.

    abstract::Increasing evidence indicates that disruption of circadian rhythms may be directly linked to cancer. Here we report that the expression levels of the core clock genes Per1 and Per3 measured by droplet digital polymerase chain reaction are significantly decreased in tumour tissue from 16 patients undergoing colorectal ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1571079

    authors: Orhan T,Nielsen PB,Hviid TVF,Rosen AW,Gögenür I

    更新日期:2019-01-01 00:00:00

  • Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?

    abstract::For women with hormone receptor-positive disease, the third-generation aromatase inhibitors (AIs), anastrozole, letrozole, and exemestane, are more effective than tamoxifen in improving disease-free survival (DFS) when used initially or as adjuvant therapy following two to three years of tamoxifen or after tamoxifen h...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701781812

    authors: Tang SC

    更新日期:2008-06-01 00:00:00

  • Single Center Experience on Anatomy-and Histopathology-Based Gastric Cancer Molecular Classification.

    abstract::We analyzed the clinical utility of molecular classification based on anatomical and histological background. The study was conducted on 457 patients treated for gastric cancer with additional information about microsatellite instability status. We divided the patients in three groups of molecular classification based...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2017.1292519

    authors: Polom K,Marrelli D,Roviello G,Voglino C,Vindigni C,Generali D,Roviello F

    更新日期:2017-05-28 00:00:00

  • The biology of interleukin-5 and its receptor.

    abstract::IL-5 is primarily a T-cell-derived cytokine that has multiple regulatory functions on eosinophils and (in the mouse) on antibody-secreting B cells. A complex network of cytokines appear to control transcription of the gene for IL-5 and its production. Abnormally high levels of this cytokine are associated with infecti...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909309011681

    authors: Mahanty S,Nutman TB

    更新日期:1993-01-01 00:00:00

  • An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation.

    abstract::Withaferin A (WA) (1) and two analogs [4-epi-withaferin A (2) and 4,27-diacetyl-4-epi-withaferin A (3)] were evaluated for antitumor activity in pancreatic cancer cells. IC(50) for 1, 2, and 3 were 0.87, 0.45, and 0.29 ?M (BxPC-3); 1.28, 1.53, and 0.52 ?M (MIAPaCa-2); and 0.59, 2.25, and 0.56 ?M (PANC-1), respectively...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.626478

    authors: Liu X,Qi W,Cooke LS,Kithsiri Wijeratne EM,Xu YM,Marron MT,Leslie Gunatilaka AA,Mahadevan D

    更新日期:2011-12-01 00:00:00

  • Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer.

    abstract::Human mesenchymal stem cells (hMSCs) play an important role in the development of human cancers. In the present study, we observed that hMSCs promoted human prostate cancer (PCa) cell PC-3 growth in vivo and in vitro. The conditional medium of hMSCs promoted the proliferation, migration, and invasion of PC-3 cells. Th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.692171

    authors: Ye H,Cheng J,Tang Y,Liu Z,Xu C,Liu Y,Sun Y

    更新日期:2012-08-01 00:00:00

  • Anti-angiogenic treatment of gastrointestinal malignancies.

    abstract::The scientific rationale to block angiogenesis as a treatment strategy for human cancer has been developed over the last 30 years, but is only now entering the clinical arena. Preclinical studies have demonstrated the importance of the vascular endothelial growth factor (VEGF) pathways in both physiologic and patholog...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900500360024

    authors: Salmon JS,Lockhart AC,Berlin J

    更新日期:2005-01-01 00:00:00

  • A phase I study of gemcitabine and docetaxel for advanced stage solid tumors.

    abstract:BACKGROUND:We conducted a phase I study to determine the maximum tolerated dose of docetaxel in combination with gemcitabine for patients with refractory solid tumors. METHODS:From January 1998 to November 1999, we treated 28 patients on a phase I protocol with gemcitabine given at a constant dose of 800 mg/m2 i.v. ov...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.1081/cnv-120018225

    authors: Poole ME,Bernard SA,Churchel MA,Weissler MC,Calvo B,Cance W,Ollila D,Koruda M,Behrns K,Detterbeck FC

    更新日期:2003-06-01 00:00:00

  • A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.

    abstract::Standard chemotherapeutic regimens, such as cisplatin and etoposide, may improve quality of life and prolong survival in patients with incurable non-small cell lung cancer (NSCLC). This trial was designed to evaluate the activity and toxicity of a regimen combining three of the most active agents against advanced-stag...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357900009023055

    authors: Ali MA,Kraut MJ,Valdivieso M,Wozniak AJ,Cummings G,Kalemkerian GP

    更新日期:2000-01-01 00:00:00

  • Adeno-associated virus harboring fusion gene NT4-ant-shepherdin induce cell death in human lung cancer cells.

    abstract::To further enhance anticancer effect of Shepherdin and overcome limitation of peptide therapy, recombinant adeno-associated virus (rAAV) was constructed with following strategies: therapeutic peptide secretory expression and adeno-associated virus gene transfer system. MTT assay and flow cytometric analysis revealed t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903095706

    authors: Xiaojiang T,Jinsong Z,Jiansheng W,Chengen P,Guangxiao Y,Quanying W

    更新日期:2010-06-01 00:00:00

  • Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.

    abstract::This case control study investigated whether polymorphisms of estrogen metabolizing genes CYP1A1 MspI, CYP17 MspAI, COMT Val(158) Met, and SULT1A1 Arg(213) His have any role in familial breast cancer susceptibility risk. Logistic regression analysis adjusted to age was used to calculate odds ratios (ORs) and 95% confi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900902744494

    authors: Syamala VS,Syamala V,Sheeja VR,Kuttan R,Balakrishnan R,Ankathil R

    更新日期:2010-03-01 00:00:00

  • Reversible deficiency of serum high density lipoproteins in Hodgkin's disease.

    abstract::An elderly woman with Hodgkin's disease and hepatic involvement but without cholestasis presented with markedly depressed levels of serum esterified cholesterol and high density lipoproteins (HDL). Within five days of her first cycle of chemotherapy her serum HDL-cholesterol rose from 8-10 mg/dl to 88 mg/dl, and level...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609017510

    authors: Herbert PN,Friedland ML

    更新日期:1986-01-01 00:00:00

  • G1 cyclins and control of the cell division cycle in normal and transformed cells.

    abstract::The G1 cyclins are clearly important factors that control progression through the eukaryotic cell cycle. The expression and activity of these factors are regulated at many different levels and in response to a large number of signals. Such complicated, multilevel controls on expression and activation of cyclin/cdk com...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909709115767

    authors: Hamel PA,Hanley-Hyde J

    更新日期:1997-01-01 00:00:00

  • Quantitative analysis of tight junctions and the uptake of 99mTc in human gliomas.

    abstract::The structural dimensions of capillary tight junctions and the uptake of 99mTc pertechnetate in human gliomas were studied. Quantitative analysis revealed a correlation between the uptake of radionuclides and the length of endothelial tight junctions. It is suggested that brain scintigraphy might be used for the selec...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609039831

    authors: Nir I,Kohn S,Doron Y,Israel O,Front D

    更新日期:1986-01-01 00:00:00

  • Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer.

    abstract::The efficacy of dose-intense methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy relative to conventional-dose M-VAC in patients with advanced transitional cell carcinoma is unknown. The outcomes of 33 patients on two successive protocols using dose-intense M-VAC with granulocyte colony-stimulat...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.3109/07357900009032829

    authors: Dodd PM,McCaffrey JA,Mazumdar M,Scher H,Higgins G,Boyle MG,Herr H,Bajorin DF

    更新日期:2000-01-01 00:00:00

  • Necrotic lung and bronchopleural fistula as complications of therapy in lung cancer.

    abstract::Seven patients developed a lung abscess and bronchopleural fistula after undergoing aggressive treatment of their lung cancer with radiotherapy +/- chemotherapy. These complications were preceded by a prodrome of recurrent bronchitis with increasing refractoriness to antibiotics, weight loss, fever, and generalized de...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077041

    authors: Frytak S,Lee RE,Pairolero PC,Arnold PG,Shaw JN

    更新日期:1988-01-01 00:00:00

  • Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.

    abstract::There is no known effective salvage chemotherapy for patients with refractory or relapsed urothelial tumors after methotrexate/cisplatin-based regimen. We report the results of a phase II trial with the FIFO regimen that includes from day 1 to 5: fluorouracil 350 mg/m2, folinic acid 20 mg/m2, and ifosfamide 1000 mg/m2...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509094462

    authors: Kattan J,Culine S,Theodore C,Droz JP

    更新日期:1995-01-01 00:00:00

  • DNA biomarkers antecede semiquantitative anthracycline cardiomyopathy.

    abstract::Adriamycin (ADM, or doxorubicin hydrochloride) is an effective antineoplastic agent whose use is restricted by its well-described, dose-dependent cardiotoxicity. This study measures ADM DNA adduct formation by 32P-radiolabeling DNA, enzymatically digesting radiolabeled DNA, separating the formed adducts on two-dimensi...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-120016404

    authors: Hahm S,Dresner HS,Podwall D,Golden M,Winiarsky R,Moosikasuwan M,Cajigas A,Steinberg JJ

    更新日期:2003-01-01 00:00:00

  • Malignant melanoma in an HIV-infected man: a case report and literature review.

    abstract::Although it is not proven by causative association, several studies indicate that patients with acquired immune deficiency syndrome (AIDS) have a high risk for developing cutaneous malignancies, especially lymphoma and Kaposi's sarcoma. Other malignant cutaneous lesions seen in this patient population include basal-ce...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909809039770

    authors: Aboulafia DM

    更新日期:1998-01-01 00:00:00

  • In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.

    abstract::In vivo and in vitro observations of cellular immune response in 70 patients with squamous cell cancer of the oral cavity and in 40 age-matched normal controls, were made using delayed hypersensitivity responses to DNCB, PPD, and Candida albicans extract (Dermatophytin 'O'), absolute lymphocyte counts, absolute T-cell...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609018450

    authors: Das SN,Khanna NN,Khanna S

    更新日期:1986-01-01 00:00:00

  • Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.

    abstract::To identify the relevant CpG sites as molecular markers, for the diagnosis and to distinguish the indolent and aggressive prostate tumors, we have determined the methylation status of 8 genes, including FLNC, EFS, ECRG4, RARB2, PITX2, GSTP1, PDLIM4, and KCNMA1 in 32 nonrecurrent, 32 recurrent primary prostate tumors, ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802620794

    authors: Vanaja DK,Ehrich M,Van den Boom D,Cheville JC,Karnes RJ,Tindall DJ,Cantor CR,Young CY

    更新日期:2009-06-01 00:00:00